149 related articles for article (PubMed ID: 19373470)
1. Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.
Krombach GA; Hahnen C; Lodemann KP; Krämer N; Schoth F; Neizel M; Boeringer J; Günther RW; Kelm M; Kühl H
Eur Radiol; 2009 Sep; 19(9):2136-46. PubMed ID: 19373470
[TBL] [Abstract][Full Text] [Related]
2. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
3. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
[TBL] [Abstract][Full Text] [Related]
4. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of using half-dose Gd-BOPTA for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the knee, compared with standard-dose Gd-DTPA.
Rehnitz C; Do T; Klaan B; Burkholder I; Barié A; Wuennemann F; Kauczor HU; Weber MA
J Magn Reson Imaging; 2020 Jan; 51(1):144-154. PubMed ID: 31141254
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
7. Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine.
Kawel N; Nacif M; Santini F; Liu S; Bremerich J; Arai AE; Bluemke DA
J Magn Reson Imaging; 2012 Sep; 36(3):733-7. PubMed ID: 22488770
[TBL] [Abstract][Full Text] [Related]
8. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
Holman ER; van Rossum AC; Doesburg T; van der Wall EE; de Roos A; Visser CA
Magn Reson Imaging; 1996; 14(1):21-9. PubMed ID: 8656987
[TBL] [Abstract][Full Text] [Related]
9. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
Galea N; Francone M; Zaccagna F; Ciolina F; Cannata D; Algeri E; Agati L; Catalano C; Carbone I
Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
[TBL] [Abstract][Full Text] [Related]
10. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI.
Wendland MF; Saeed M; Lauerma K; Derugin N; Mintorovitch J; Cavagna FM; Higgins CB
Magn Reson Med; 1997 Mar; 37(3):448-56. PubMed ID: 9055236
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
12. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA
Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071
[TBL] [Abstract][Full Text] [Related]
13. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
Doltra A; Skorin A; Hamdan A; Schnackenburg B; Gebker R; Klein C; Nagel E; Fleck E; Kelle S
Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine.
Tumkosit M; Puntawangkoon C; Morgan TM; Clark HP; Hamilton CA; Ntim WO; Clark PB; Hundley WG
J Comput Assist Tomogr; 2009; 33(3):328-33. PubMed ID: 19478622
[TBL] [Abstract][Full Text] [Related]
15. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
18. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
19. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
[TBL] [Abstract][Full Text] [Related]
20. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
